Luminopia Announces First International Licensing Agreement With ROHTO Pharmaceutical to Launch Pediatric Amblyopia Treatment in Japan
CAMBRIDGE, Mass.—Luminopia Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, announced its first international licensing agreement with ROHTO Pharmaceutical Co. Ltd., a…









